RTI-171

From Wikipedia, the free encyclopedia
Jump to: navigation, search
RTI-171
RTI-171 structure.png
Systematic (IUPAC) name
3-methyl-5-[(1S,3S,4S,5R)-8-methyl-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octan-4-yl]-1,2-oxazole
Clinical data
Identifiers
PubChem CID 10565888
Chemical data
Formula C19H24N2O
296.406 g/mol
 YesY (what is this?)  (verify)

(–)-2β-(3-Methylisoxazol-5-yl)-3β-(p-tolyl)tropane (RTI-171) is a phenyltropane derivative which acts as a selective dopamine reuptake inhibitor, with a relatively slow onset of action and short duration of effects found in animal studies.[1]

See also[edit]

References[edit]

  1. ^ Kimmel HL, Carroll FI, Kuhar MJ (December 2001). "Locomotor stimulant effects of novel phenyltropanes in the mouse". Drug and Alcohol Dependence 65 (1): 25–36. doi:10.1016/S0376-8716(01)00144-2. PMID 11714587.